Skip header and navigation

3 records – page 1 of 1.

Nova Scotia Health Authority. Central Zone. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
0249
Available Online
View Pamphlet
This pamphlet will inform the reader about clopidogrel and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Anticoagulants
Subjects (LCSH)
Anticoagulants (Medicine)
Specialty
Medications
Abstract
This pamphlet will inform the reader about clopidogrel and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0249
Less detail
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0373
Available Online
View Pamphlet
This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
Notes
Previous title: Warfarin sodium, an oral anticoagulant
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
0373
Less detail

Warfarine sodique

https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2063
Available Online
View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Warfarin sodium
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
2063
Less detail